Medigen Biotechnology (3176) — Financial Flexibility Index
Medigen Biotechnology (3176) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of NT$19.87 Million (operating CF NT$-18.91 Million minus capex NT$38.78 Million) represents 0% of total liabilities (NT$1.45 Billion). Check 3176 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medigen Biotechnology Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Medigen Biotechnology across 12 annual periods. For the full cash flow conversion analysis, see 3176 cash flow conversion.
Annual Financial Flexibility Index for Medigen Biotechnology (2003–2024)
Year-by-year free cash flow to debt coverage for Medigen Biotechnology. Explore Medigen Biotechnology cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | NT$96.59 Million | NT$37.92 Million | NT$1.67 Billion | ▲ +139.3% |
| 2023 | -0.15x | NT$-518.48 Million | NT$-569.40 Million | NT$3.53 Billion | ▲ +47.2% |
| 2022 | -0.28x | NT$-976.29 Million | NT$-1.13 Billion | NT$3.51 Billion | ▼ -174.5% |
| 2021 | 0.37x | NT$662.00 Million | NT$517.45 Million | NT$1.77 Billion | ▲ +216.2% |
| 2020 | -0.32x | NT$-531.09 Million | NT$-671.38 Million | NT$1.65 Billion | ▼ -54.3% |
| 2019 | -0.21x | NT$-446.32 Million | NT$-560.17 Million | NT$2.14 Billion | ▲ +14.9% |
| 2018 | -0.24x | NT$-405.69 Million | NT$-529.82 Million | NT$1.66 Billion | ▼ -20.0% |
| 2017 | -0.20x | NT$-344.89 Million | NT$-455.62 Million | NT$1.69 Billion | ▼ -368.5% |
| 2016 | 0.08x | NT$97.61 Million | NT$-468.61 Million | NT$1.28 Billion | ▼ -90.3% |
| 2015 | 0.79x | NT$809.42 Million | NT$294.18 Million | NT$1.03 Billion | ▼ -51.5% |
| 2005 | 1.62x | NT$83.93 Million | NT$80.72 Million | NT$51.78 Million | ▼ -60.3% |
| 2003 | 4.08x | NT$449.42 Million | NT$445.46 Million | NT$110.16 Million | — |